Tuesday, April 02, 2019 8:57:24 AM
A trade off for growth?
Recent SMTI News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/17/2026 08:05:08 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/17/2026 11:40:31 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/17/2026 11:35:27 AM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/17/2026 11:30:40 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/16/2026 08:05:23 PM
- Sanara MedTech Inc. to Report First Quarter 2026 Financial Results on May 12, 2026 • GlobeNewswire Inc. • 04/14/2026 11:30:00 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/24/2026 08:02:33 PM
- Sanara MedTech shares rise more than 3% despite fourth-quarter earnings miss • IH Market News • 03/24/2026 01:52:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 11:10:13 AM
- Sanara MedTech Inc. Reports Fourth Quarter (Unaudited) and Full Year 2025 Financial Results; Reaffirmed Full Year 2026 Financial Guidance • GlobeNewswire Inc. • 03/24/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 08:35:12 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 08:33:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 08:33:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/23/2026 08:32:00 PM
- Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds • GlobeNewswire Inc. • 03/11/2026 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/10/2026 08:02:15 PM
- Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 • GlobeNewswire Inc. • 03/03/2026 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 01:52:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 09:11:01 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2026 09:27:51 PM
- Sanara MedTech Inc. to Participate in the TD Cowen 46th Annual Health Care Conference on March 3rd • GlobeNewswire Inc. • 02/17/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/23/2026 12:45:35 PM
